Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ocular Research of Boston is a specialized clinical research organization and center of excellence focused on ophthalmology and optometry. Founded by Dr. Donald Korb, the entity is globally recognized for its pioneering research into dry eye disease and meibomian gland dysfunction (MGD). The organization operates as a high-level clinical trial site, partnering with major pharmaceutical and medical device companies to evaluate new ocular therapies and diagnostic tools. It has been instrumental in the development of landmark technologies, including the LipiFlow Thermal Pulsation System and various advanced contact lens designs. Beyond clinical trials, the group provides consulting services for product development and diagnostic innovation within the vision care industry. Its work continues to set the standard for the clinical understanding of the tear film and ocular surface health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ocular Research of Boston.